Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:2978-2984
Published online before print October 24, 2002, doi: 10.1161/01.STR.0000038093.42512.0F
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
33/12/2978    most recent
01.STR.0000038093.42512.0Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saulle, E.
Right arrow Articles by Calabresi, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saulle, E.
Right arrow Articles by Calabresi, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE
*GLUCOSE
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Brain Circulation and Metabolism

(Stroke. 2002;33:2978.)
© 2002 American Heart Association, Inc.


Original Contributions

Endogenous Dopamine Amplifies Ischemic Long-Term Potentiation via D1 Receptors

Emilia Saulle, MD; Diego Centonze, MD; Ana B. Martín, PhD; Rosario Moratalla, PhD; Giorgio Bernardi, MD Paolo Calabresi, MD

From Clinica Neurologica, Dipartimento di Neuroscienze, Università "Tor Vergata," and IRCCS Fondazione Santa Lucia, Rome, Italy (E.S., D.C., G.B., P.C.); and Instituto Cajal, Consejo Superior de Investigaciones Científicas, Madrid, Spain (A.B.M., R.M.).

Correspondence to Paolo Calabresi, MD, Clinica Neurologica, Dipartimento di Neuroscienze, Università "Tor Vergata," Via di Tor Vergata 135, 00133 Rome, Italy. E-mail calabre{at}uniroma2.it

Background and Purpose— Several observations indicate that, during energy deprivation, endogenous dopamine may become neurotoxic. Accordingly, the nucleus striatum is a preferential site of silent infarcts in humans, and experimental ischemia caused by homolateral carotid occlusion selectively damages this dopamine-enriched brain area. In an attempt to clarify how dopamine takes part in ischemia-induced neuronal damage, we performed in vitro electrophysiological recordings from neurons of the nucleus striatum.

Methods— Intracellular recordings with sharp microelectrodes were performed from corticostriatal slices. Slices were obtained from both rats and wild-type and dopamine D1 receptor-lacking mice. In some experiments, the striatum was unilaterally denervated by injecting the dopamine-specific neurotoxin 6-hydroxydopamine in the homolateral substantia nigra. Dopamine agonists and antagonists, as well as drugs targeting the intracellular cascade coupled to dopamine receptor stimulation, were applied at known concentrations.

Results— Manipulation of the dopamine system failed to affect the membrane depolarization of striatal neurons exposed to combined oxygen and glucose deprivation of short duration, but it reduced the amplitude of postischemic long-term potentiation (LTP) expressed at corticostriatal synapses. In particular, pharmacological blockade or genetic inactivation of D1/cAMP/protein kinase A pathway prevented the long-term increase of the excitatory postsynaptic potential (EPSP) amplitude caused by a transient ischemic episode, while it failed to prevent the increase of the EPSP half-decay coupled to ischemic LTP.

Conclusions— The present data suggest that endogenous dopamine, via D1 receptors, selectively facilitates the expression of ischemic LTP on the AMPA-mediated component of the EPSPs, while it does not alter the expression of this form of synaptic plasticity on the N-methyl-D-aspartate-mediated component of corticostriatal synaptic potentials. Understanding the cellular and molecular mechanisms of ischemia-triggered excitotoxicity offers hope for the development of specific treatments able to interfere with this pathological process.


Key Words: apoptosis • electrophysiology • energy metabolism • excitotoxicity • neuronal plasticity • synapses




This article has been cited by other articles:


Home page
StrokeHome page
Y. Zhang, P. Deng, Y. Ruan, and Z. C. Xu
Dopamine D1-Like Receptors Depress Excitatory Synaptic Transmissions in Striatal Neurons After Transient Forebrain Ischemia
Stroke, August 1, 2008; 39(8): 2370 - 2376.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Picconi, A. Tortiglione, I. Barone, D. Centonze, F. Gardoni, P. Gubellini, P. Bonsi, A. Pisani, G. Bernardi, M. Di Luca, et al.
NR2B Subunit Exerts a Critical Role in Postischemic Synaptic Plasticity
Stroke, July 1, 2006; 37(7): 1895 - 1901.
[Abstract] [Full Text] [PDF]